Holdings
Lord Abbett Micro-Cap Growth Fund
As of Jul 31, 2026, Lord Abbett Micro-Cap Growth Fund reported 82 positions worth US$206M. Largest: Cogent Biosciences, Inc., Forte Biosciences, Inc. and Adaptive Biotechnologies Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cogent Biosciences, Inc. | 150K | US$5.85M | −35,286 | Jul 31, 2026 |
| Forte Biosciences, Inc. | 73,673 | US$5.64M | +41,381 | Jul 31, 2026 |
| Adaptive Biotechnologies Corporation | 247K | US$5.58M | −76,746 | Jul 31, 2026 |
| Aehr Test Systems | 69,289 | US$5.54M | −951 | Jul 31, 2026 |
| Navan, Inc. | 203K | US$5.41M | −8,957 | Jul 31, 2026 |
| Enliven Therapeutics, Inc. | 90,937 | US$4.98M | +45,411 | Jul 31, 2026 |
| Lindblad Expeditions Holdings Inc. | 153K | US$4.52M | +1,512 | Jul 31, 2026 |
| Ceco Environmental Corp. | 64,212 | US$4.23M | +9,388 | Jul 31, 2026 |
| 10x Genomics, Inc. | 89,105 | US$4.21M | −3,679 | Jul 31, 2026 |
| Pattern Group Inc. - Series A | 172K | US$3.97M | +42,590 | Jul 31, 2026 |